Welcome, Tester!
New test results: We received your newest liquid biopsy results on January 24th and you have a new NF1 mutation that may make you eligible for a clinical trial. See your biomarker test results.
Recommended reading: We added a new article explaining the NF1 gene. Learn more about the NF1 gene over on the Encyclopedia of Precision Medicine.
Your treatment plan and goals at a glance
Pembrolizumab
Taking since: 2023-08-30
See your full health history
Your personal biology
BRCA2
Your BRCA2 mutation may make you eligible to take a PARP inhibitor.
TMB
Status: High
Patients who are TMB-high often respond well to ICIs.